Latest Regulatory Filings News

Page 49 of 54
Auric Mining Limited reports a robust cash flow quarter ending December 31, 2024, with current assets reaching approximately $10 million and ongoing cash inflows from its joint venture at Jeffreys Find Gold Mine.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Neurotech International has secured a $2.44 million R&D tax incentive refund, strengthening its cash position as it advances clinical trials for paediatric neurological disorders and prepares for regulatory submissions in FY2025.
Ada Torres
Ada Torres
31 Jan 2025
Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.
Ada Torres
Ada Torres
30 Jan 2025
BlinkLab has launched its pivotal FDA registrational study for its AI-driven autism diagnostic app, BlinkLab Dx 1, following positive FDA feedback and promising preliminary results.
Ada Torres
Ada Torres
30 Jan 2025
Impact Minerals Limited reported its December 2024 quarterly cash flow, revealing ongoing exploration expenditures and a significant $2.87 million grant to commercialise its High Purity Alumina process at Lake Hope.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Bluechiip Limited reported a $221,000 net cash outflow for Q2 FY2025, with cash reserves dwindling to $121,000. The company has initiated a strategic review and plans a capital raise to secure its future.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.
Ada Torres
Ada Torres
30 Jan 2025
Tlou Energy Limited reported a challenging quarter with significant cash outflows from operations and investing activities, while actively pursuing additional funding to sustain its exploration efforts.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Cycliq Group Limited reported a robust net operating cash flow of $964,000 for the December 2024 quarter, bolstered by government grants and disciplined cost management. The company ended the period with a healthy cash balance of $1.12 million, signaling improved liquidity.
Sophie Babbage
Sophie Babbage
30 Jan 2025
IXUP Limited reports strong sales momentum driven by its largest-ever contract with iGaming Ontario, alongside strategic cost reductions and a clear path to positive cash flow by late 2025.
Sophie Babbage
Sophie Babbage
30 Jan 2025
ASF Group Limited reported a $1.58 million cash balance for the December 2024 quarter, highlighting ongoing investments and a director retirement that could influence its strategic direction.
Victor Sage
Victor Sage
30 Jan 2025
InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.
Ada Torres
Ada Torres
30 Jan 2025